Our results, for the first time, highlighted that Jmjd3 plays a key role in the inflammatory response to CUMS and mediates the susceptibility to depression by regulating microglial activation and pro-inflammatory cytokine expression in the prefrontal cortex and hippocampus. The gene discussed is KDM6B; the disease is depressive disorder.